Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 4643.78 | 180 / 180 | 100% | 685.42 | 430 / 430 |
lung | 100% | 3584.35 | 576 / 578 | 98% | 321.63 | 1133 / 1155 |
skin | 100% | 4523.11 | 1809 / 1809 | 97% | 313.90 | 457 / 472 |
uterus | 100% | 4596.22 | 170 / 170 | 96% | 309.19 | 442 / 459 |
brain | 97% | 2410.67 | 2550 / 2642 | 99% | 188.67 | 695 / 705 |
esophagus | 100% | 2765.86 | 1442 / 1445 | 93% | 211.02 | 171 / 183 |
stomach | 100% | 3146.88 | 359 / 359 | 92% | 214.22 | 264 / 286 |
breast | 100% | 3294.43 | 459 / 459 | 91% | 259.75 | 1020 / 1118 |
pancreas | 97% | 2438.99 | 317 / 328 | 94% | 151.38 | 168 / 178 |
bladder | 100% | 3939.10 | 21 / 21 | 88% | 183.64 | 444 / 504 |
intestine | 100% | 2668.04 | 966 / 966 | 88% | 185.82 | 464 / 527 |
kidney | 100% | 5665.09 | 89 / 89 | 80% | 116.04 | 718 / 901 |
thymus | 100% | 3425.91 | 653 / 653 | 70% | 66.31 | 422 / 605 |
adrenal gland | 100% | 4817.59 | 258 / 258 | 63% | 83.33 | 145 / 230 |
liver | 77% | 1277.55 | 174 / 226 | 64% | 112.81 | 258 / 406 |
prostate | 99% | 2842.78 | 243 / 245 | 25% | 20.51 | 124 / 502 |
muscle | 100% | 5667.33 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4204.43 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 139.74 | 1 / 1 |
adipose | 100% | 2861.84 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2832.32 | 1329 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 463.31 | 79 / 80 |
tonsil | 0% | 0 | 0 / 0 | 98% | 185.19 | 44 / 45 |
heart | 97% | 10866.01 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 11% | 192.34 | 105 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_1905166 | Biological process | negative regulation of lysosomal protein catabolic process |
GO_0097213 | Biological process | regulation of lysosomal membrane permeability |
GO_0032911 | Biological process | negative regulation of transforming growth factor beta1 production |
GO_0032509 | Biological process | endosome transport via multivesicular body sorting pathway |
GO_0007032 | Biological process | endosome organization |
GO_1905671 | Biological process | regulation of lysosome organization |
GO_0031902 | Cellular component | late endosome membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005769 | Cellular component | early endosome |
GO_0005764 | Cellular component | lysosome |
GO_0097487 | Cellular component | multivesicular body, internal vesicle |
GO_0042995 | Cellular component | cell projection |
GO_0005768 | Cellular component | endosome |
GO_0032585 | Cellular component | multivesicular body membrane |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0097001 | Molecular function | ceramide binding |
GO_0019900 | Molecular function | kinase binding |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_1902936 | Molecular function | phosphatidylinositol bisphosphate binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LAPTM4B |
Protein name | LAPTM4B (Lysosome-associated protein transmembrane 4 beta) Lysosomal protein transmembrane 4 beta Lysosomal-associated transmembrane protein 4B (Lysosome-associated transmembrane protein 4-beta) |
Synonyms | PSEC0001 |
Description | FUNCTION: Required for optimal lysosomal function . Blocks EGF-stimulated EGFR intraluminal sorting and degradation. Conversely by binding with the phosphatidylinositol 4,5-bisphosphate, regulates its PIP5K1C interaction, inhibits HGS ubiquitination and relieves LAPTM4B inhibition of EGFR degradation . Recruits SLC3A2 and SLC7A5 (the Leu transporter) to the lysosome, promoting entry of leucine and other essential amino acid (EAA) into the lysosome, stimulating activation of proton-transporting vacuolar (V)-ATPase protein pump (V-ATPase) and hence mTORC1 activation . Plays a role as negative regulator of TGFB1 production in regulatory T cells . Binds ceramide and facilitates its exit from late endosome in order to control cell death pathways . . |
Accessions | ENST00000517924.5 ENST00000521545.7 [Q86VI4-2] H0YBN1 ENST00000445593.6 [Q86VI4-3] ENST00000619747.1 [Q86VI4-3] Q86VI4 Q86SJ0 |